A 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer

tthunderbong about 3 hours ago 2 commentsRead Article on imapac.com

DE version is available. Content is displayed in original English for accuracy.

⚡ Community Insights

Discussion Sentiment

0% Positive

Analyzed from 59 words in the discussion.

Discussion (2 Comments)Read Original on HackerNews

nose•about 2 hours ago

Why is a randomized controlled study needed for these scenarios in a clinical trial. If the patient is known to have a fatal disease in the study, why not give them the proposed treatment? The alternative is much worse.

WalterGR•about 2 hours ago

Are you talking about the word “randomly” in the following text?

> …the BIOMEDE study, which began in 2014 and compared three drug candidates: erlotinib, everolimus, and dasatinib. … Lucas was randomly assigned to receive everolimus.